Welcome
Dear visitors, members and future members,
CARS welcomes you to our new home. You are welcome to share your ideas, developments and latest results of your research with your colleagues and other professionals with interest in radiopharmaceutical sciences.
The new website is a friendly environment where everyone is welcomed. Join CARS, access the member reserved area, and you will find more.
We hope that you enjoy your journey and that you will join us to enrich the community of radiopharmaceutical scientists.
Canadian Association of
Radiopharmaceutical Scientists (CARS)
Activities:
- Hold scientific meetings at which members may discuss their work; such meetings need not necessarily be held on a regular basis;
- Monitor and where necessary, respond to government actions which affect either the routine preparation of radiopharmaceuticals or radiopharmaceutical research and development;
- Monitor and respond to actions of any third party which have an effect on professional practice of the members of the Association.
- Facilitate open discussions between community members
Who We Are
CARS is a professional association established with the objective of the communication of radiopharmaceutical and scientific knowledge.
Stakeholders of CARS include public at large, scientists and those with professional interest in any aspect of radiopharmaceutical sciences. CARS is facilitating an open communication between all categories of stakeholders.
Professional Development
Our members have access to the latest resources for professional development in radiopharmaceutical sciences.
Members
Only
You have access to regulatory information, latest communications in the field and updates regarding the market trends and developments in the field
CARS Forum
CARS is welcoming you to share your ideas, news, events and topics related to radiopharmaceutical sciences on our new forum.
The space is designed to strengthen our community and to encourage open communication about your progress, challenges or new ideas.
Latest News
CARS aim to provide information for educational and information only purposes.
- March 18, 2020
Mo-99 supply
In a recent release, SNMMI notifies that Mo-99 supply might be disrupted due to the overall changes in the supply chain following the outbreak of COVID-19
Read More - March 17, 2020
CARS Response to COVID-19
The Canadian Association of Radiopharmaceutical Scientists (CARS) is closely monitoring the global developments related to the COVID-19 and potential challenges this will have on the field of radiopharmaceutical preparation and manufacturing. To our knowledge, as of today no disruption in the regular operations in manufacturing of radiopharmaceuticals is reported
Read More - February 17, 2020
EANM guideline on the validation of analytical methods for radiopharmaceuticals
A recently published article in the European Journal of Nuclear Medicine and Molecular Imaging provides us with an overview on the EANM guideline on the validation of analytical methods for radiopharmaceuticals. Download the article for free from EANM Guideline.
Read More
